Literature DB >> 4204165

Propranolol given twice daily in hypertension.

G Berglund, O Andersson, L Hansson, R Olander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4204165     DOI： 10.1111/j.0954-6820.1973.tb19483.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  10 in total

1.  A practical approach to hypertension.

Authors:  A Dodek; G Wilkins
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

2.  Antihypertensive efficacy of propranolol given twice daily.

Authors:  S M MacLeod; P Hamet; H Kaplan; P Larochelle; J Nadeau; R I Ogilvie; R E Rangno; J Ruedy; E M Sellers; T Y Ti
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

3.  Plasma concentrations of propranolol in patients with essential hypertension.

Authors:  A Lehtonen; J Kanto; T Kleimola
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

4.  Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.

Authors:  J McAinsh; N S Baber; R Smith; J Young
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

Review 5.  Antihypertensive pharmacology.

Authors:  J G Gerber; C R Freed; A S Nies
Journal:  West J Med       Date:  1980-05

6.  Theoretical Michaelis-Menten elimination model for propranolol.

Authors:  J McAinsh; M A Gay
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jul-Sep       Impact factor: 2.441

7.  Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.

Authors:  W J Leahey; J D Neill; M P Varma; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

8.  Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.

Authors:  N Himori; S Honma; A Izumi; T Ishimori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

9.  Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.

Authors:  D P Nicholls; D W Harron; J McAinsh; W M Castle; N P Barker; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

10.  Transmissible ER stress reconfigures the AML bone marrow compartment.

Authors:  Ben Doron; Sherif Abdelhamed; John T Butler; Saman K Hashmi; Terzah M Horton; Peter Kurre
Journal:  Leukemia       Date:  2018-09-11       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.